Danimer Scientific, Inc.
DNMR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$155,473 | -$179,758 | -$60,107 | -$12,573 |
| Dep. & Amort. | $29,058 | $20,086 | $10,634 | $5,123 |
| Deferred Tax | -$199 | -$814 | -$13,233 | -$5,275 |
| Stock-Based Comp. | $56,035 | $56,958 | $55,270 | $3,645 |
| Change in WC | $13,502 | -$19,321 | -$28,874 | -$7,181 |
| Other Non-Cash | $9,813 | $61,012 | -$26,653 | $2,464 |
| Operating Cash Flow | -$47,264 | -$61,837 | -$62,963 | -$13,797 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$27,685 | -$164,486 | -$185,411 | -$38,268 |
| Net Acquisitions | $0 | -$14 | -$151,179 | $9 |
| Inv. Purchases | $0 | -$18,037 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $18,037 | $0 | $0 |
| Other Inv. Act. | $22 | -$17,982 | $422 | $0 |
| Investing Cash Flow | -$27,663 | -$182,482 | -$336,168 | -$38,259 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $83,674 | $23,196 | $213,083 | $2,606 |
| Stock Issued | $225 | $0 | $140,311 | $32,518 |
| Stock Repurch. | $0 | -$236 | -$1,728 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $131 | -$1,208 | $94,009 | $387,551 |
| Financing Cash Flow | $84,030 | $21,752 | $306,202 | $422,675 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $9,103 | -$222,567 | -$92,929 | $370,619 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $64,401 | $286,968 | $379,897 | $9,278 |
| End Cash | $73,504 | $64,401 | $286,968 | $379,897 |
| Free Cash Flow | -$74,949 | -$226,323 | -$248,374 | -$52,065 |